Transmedics
TMDX
124 hedge funds and large institutions have $625M invested in Transmedics in 2021 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 35 increasing their positions, 41 reducing their positions, and 13 closing their positions.
131% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 13
44% more call options, than puts
Call options by funds: $9.53M | Put options by funds: $6.62M
16% more funds holding
Funds holding: 107 → 124 (+17)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.03% less ownership
Funds ownership: 68.13% → 68.09% (-0.03%)
15% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 41
19% less capital invested
Capital invested by funds: $775M → $625M (-$150M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$15.3M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$8.92M |
| 3 |
State Street
Boston,
Massachusetts
|
+$8.25M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$6.89M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.73M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$16.8M |
| 2 |
ZP
Zimmer Partners
New York
|
-$12.4M |
| 3 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$8.44M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$7.06M |
| 5 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$6.41M |
TMDX Hedge Fund Activity: Q2 2021 in Review
124 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Transmedics (TMDX) for Q2 2021, worth a combined $625M — down 19% from $775M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new TMDX positions and 13 closed out — a net gain of 17 holders — while 35 added to existing stakes and 41 trimmed.
The largest buyer was Macquarie Group, adding an estimated $15.3M. The largest seller was Federated Hermes, cutting an estimated $16.8M.
- 124 institutional investors held Transmedics (TMDX) as of Q2 2021, up from 107 in Q1 2021.
- Funds reported $625M of Transmedics stock for Q2 2021, down 19% quarter-over-quarter.
- 30 funds opened new Transmedics positions in Q2 2021 and 13 closed out, a net change of +17 holders.
- The largest Transmedics buyer in Q2 2021 was Macquarie Group, an estimated $15.3M added.
- The largest Transmedics seller in Q2 2021 was Federated Hermes, an estimated $16.8M sold.
Based on aggregated 13F filings for Q2 2021.